Molecular Vision 2010; 16:1920-1927 <http://www.molvis.org/molvis/v16/a209>
Received 5 July 2010 | Accepted 16 September 2010 | Published 2 October 2010

This Article

Download PDF

Citation (for Endnote)

Google Scholar

Articles by the Authors

Evaluation of BLID and LOC399959 as candidate genes for high myopia in the Chinese Han population

Fuxin Zhao,1,3 Jian Bai,2,4 Wei Chen,2,4 Anquan Xue,1,3 Chaohua Li,2 Zhonghui Yan,5 Hui Chen,6 Fan Lu,1,3 Yongwu Hu,1,3 Jia Qu,1,3 Changqing Zeng,2 Xiangtian Zhou1,3

The first two authors contributed equally to this work

1School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, China; 2Beijing Institute of Genomics, Key Laboratory of Genome Sciences and Information, Chinese Academy of Sciences, Beijing, China; 3State Key Laboratory Cultivation Base and Key Laboratory of Vision Science, Ministry of Health P.R. China and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang, China; 4Graduate School of the Chinese Academy of Sciences, Beijing, China; 5Department of Ophthalmology, Eye Hospital of Shenzhen, Shenzhen, Guangdong, China; 6Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong, Jiangshu, China

Correspondence to: Xiangtian Zhou, School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou, Zhejiang 325003, P. R. China; Phone: +86-577-88824116; FAX: +86-577-88824115; email: zxt-dr@wz.zj.cn

Abstract

Purpose: BH3-like motif containing, cell death inducer (BLID) and LOC399959 are two genes associated with the single nucleotide polymorphism (SNP) rs577948, which is a susceptibility locus for high myopia in Japanese subjects. The purpose of this study was to determine if BLID and LOC399959 are associated with high myopia in Chinese Han subjects.

Methods: High myopia subjects (n=476) had a spherical refractive error of less than −6.00 D in at least one eye and/or an axial length greater than 26 mm. Genomic DNA was extracted and genotyped from peripheral blood leukocytes of high myopes and controls (n=275). Using a case-control association study of candidate regions, linkage disequilibrium blocks for 19 tag SNPs (tSNPs), including rs577948, harbored within and surrounding the BLID and LOC399959 genes were analyzed on a MassArray platform using iPlex chemistry. Each of the tSNPs had an r2>0.8 and minor allele frequency >10% in the Chinese Han population. Haplotype association analysis was performed on Haploview 4.1 using Chi-square (χ2) tests.

Results: None of the 19 tSNPs were statistically associated with high myopia.

Conclusions: While rs577948 may be associated with high myopia in Japanese subjects, it and the other tSNPs near the BLID and LOC399959 genes are not susceptibility loci for high myopia in the Chinese Han population. Thus, associations of SNPs with high myopia as determined by Genome-Wide Association Study (GWAS) may be restricted to certain ethnic or genetically distinct populations. Without systematic replication in other populations, the results of GWAS associations should be interpreted with great caution.

Introduction

Myopia is the most common worldwide ocular disorder. The prevalence of myopia is much higher in Asians than in Caucasians and is an especially important public health issue in Asia. In Western populations, approximately 25% of the decreased vision is caused by myopia, while in some Asian regions, such as China, Singapore, Taiwan, Japan, and Hong Kong, it accounts for 60 – 80% of young adult decreased vision [1]. High myopia is an extreme form of myopia and is usually defined by the presence of an axial eye length greater than 26 mm or a refractive error of less than −6.00 diopters (D). It is usually associated with other ocular disorders such as retinal detachment, macular degeneration, cataract, and glaucoma. For this reason, it is often designated as “pathologic” myopia. High myopia is the fourth most common cause of irreversible blindness [2]. In Asia, the prevalence of high myopia is 1% to 5% [3,4], even reaching 9.1% in some regions [5].

High myopia is a complex disease associated with both genetic and environmental factors. Genetic linkage studies have so far identified 18 chromosomal regions harboring myopia-related genes (MYPs). Of these candidate loci, 11 have been associated with high myopia: MYP1–5 [2,6-9], MYP11 [10], MYP12 [11], MYP13 [12], MYP15 [13], MYP16 [14], and MYP18 [15]. In the same chromosomal regions, many candidate genes associated with high myopia have been studied, such as collagen, type I, alpha 1 (COL1A1) [16], transforming growth factor, beta 1 (TGF beta1) [17,18], transforming growth factor-beta-induced factor (TGIF) [19], lumican (LUM) [20,21], hepatocyte growth factor (HGF) [22], myocilin (MYOC) [23], paired box 6 (PAX6) [24,25], and uromodulin-like 1 (UMODL1) [26], but none of these are now thought to be responsible for or associated with high myopia.

The genome-wide association study (GWAS) is a powerful research tool, using single nucleotide polymorphisms (SNPs) as markers to identify susceptibility genes of many complex diseases, and it has been successfully applied to identify genetic risk factors for ocular diseases. In 2009, Nakanishi et al. [27] used GWAS to analyze high myopia in a Japanese population. They identified a novel susceptibility locus, rs577948, for pathological myopia at 11q24.1, and within a 200 kb region containing rs577948, they found two genes. BH3-like motif containing, cell death inducer (BLID) is a cell death inducer containing a BH3-like motif. It is located approximately 44-kb upstream of rs577948. The other gene, LOC399959, is a hypothetical non-coding RNA that encompasses a 114-kb DNA in the region, and rs577948 is located in its second intron. Because of the complexities of associating SNPs with specific disease processes in unique ethnic populations, there is no assurance that the same associations will hold for other ethnic and/or genetically distinct populations. Therefore we genotyped rs577948 and 18 other tag single nucleotide polymorphisms (tSNPs) of the BLID and LOC399959 genes to determine if they were associated with high myopia in a Chinese population.

Methods

Subjects

This study was approved by Wenzhou Medical College and by local hospital ethics committees and conducted in accordance with the Declaration of Helsinki principles. All of the subjects for this study were of the Han population from the southern regions of China. They were recruited at the Eye Hospital of Wenzhou Medical College and at local hospitals and informed consent was obtained from each one. The subjects were given complete ophthalmoscopic examinations by local ophthalmologists, including measurements of visual acuity (Topcon RM-8800; Topcon Corp., Tokyo, Japan), axial length (Zeiss IOL Master; Carl Zeiss Meditec, Jena, Germany), spherical refractive error (KOH3 Keratometer; Nikon, Tokyo, Japan), and fundus photography (Canon CR6–45NM Fundus Camera; Canon Inc., Tokyo, Japan).

Individuals with high myopia had a spherical refractive error of less than −6.00 D in at least one eye and/or an axial length greater than 26 mm. Potential subjects with other known ocular or systemic diseases such as Stickler and Marfan’s syndromes were excluded. Controls were recruited and met the following criteria: (1) had no known ocular disease or other genetic diseases or systemic connective tissue disorders associated with myopia, (2) were without family history of high myopia, (3) had spherical refractive error ranging from −0.50 to +2.00 D, and (4) had axial lengths less than 24 mm in both eyes.

DNA extraction

Genomic DNA was extracted from peripheral blood cells using QIAamp DNA Blood Mini Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s protocol. Briefly, 20 μl Qiagen Protease, 200 μl whole blood, and 200 μl AL Buffer was added to 1.5 ml microcentrifuge tube, respectively. The admixture was blended by pulse-vortexing and incubated at 56 °C for 10 min, then added 200 μl ethanol (96–100%) to mixture, centrifuged at 6,000× g (8,000 rpm) for 1 min, opened the QIAamp spin column and added 500 μl Buffer AW1, centrifuged at 6,000× g (8,000 rpm) for 1 min, added 500 μl Buffer AW2, centrifuged at 20,000× g (14,000 rpm) for 1 min. The isolated DNA was eluted in TE buffer (10 mM Tris-HCl, 0.5 mM EDTA, pH 9.0), and the A260/A280 optical density was measured by NanoDrop ND1000 (Thermo Fisher Scientific, Waltham, MA). It was then stored at −80 °C before use.

SNP selection and genotyping

To determine the association between the SNPs and the high myopic subjects, we used the tag single nucleotide polymorphisms (tSNPs) approach. The tSNPs of the BLID and LOC399959 genes were selected from the public Single Nucleotide Polymorphism database build 126 and the phase data of the HapMap Project release 27. Each tSNP met the following criteria: r2>0.8 and minor allele frequency (MAF)>10% in the Chinese Han population [28,29]. We selected 19 tSNPs to tag the linkage disequilibrium (LD) blocks harbored within and surrounding the BLID and LOC399959 genes (Table 1).

DNA samples were initially diluted to ~10 ng/µl as measured with PicoGreen Dye (Invitrogen, Carlsbad, CA) in a NanoDrop ND3300 fluorospectrometer (Thermo Fisher Scientific, Waltham, MA). The tSNPs of the BLID and LOC399959 genes were genotyped on MassArray platform using iPlex chemistry (Sequenom Inc., San Diego, CA) according to the manufacturer’s instruction. Loci with a call rate >0.8 were selected for association analysis on PLINK 1.07 and haplotype analysis on Haploview 4.1 [30].

For clinical data, means and standard errors of the means were determined. We evaluated the allele frequencies of sequence alterations in patients and controls using χ2 tests in a logistic regression model where age and gender were included as covariates. Allelic frequencies of detected SNPs in controls were also assessed for Hardy–Weinberg equilibrium. We also performed haplotype association analysis on Haploview 4.1 using χ2 tests. P-values of both single SNPs and haplotypes were corrected using permutation test after running 50,000 times.

Results

Clinical data

Bilateral high myopia was present in 476 subjects (177 men, 299 women) with a mean age of 36.8±0.7 years (range: 5–77 years), and the age of onset was 14.3±0.5 years. There were 275 control subjects (152 men; 123 women) with an age of 22.3±0.3 years (range: 17–59 years). For subjects with high myopia, the spherical refractive errors of the right and left eyes were −15.05±-0.28 D and −14.57±-0.31 D, respectively. The axial lengths of the right and left eyes were 29.83±0.12 mm and 29.55±0.14 mm, respectively.

Association analysis

After tSNP analysis of the BLID and LOC399959 genes, none of the nineteen tested tSNPs demonstrated significant association with high myopia (Table 1). Eighteen, including rs577948, failed to reach a nominal significant level (p=0.05). One tSNP, rs11604461, was nearly significant (p=0.07, Table 1), but the permutation test (Ppermutation=0.6041, Table 1) showed it was not a true association. Thus, the results of genotyping indicated that there were no significant differences in the tSNPs between high myopia and controls in the tested region.

Haplotype analysis showed that there were five LD blocks in the BLID and LOC399959 cluster regions (Figure 1). After removing haplotypes with frequencies less than 5%, we analyzed haplotype associations on the five blocks. After 50,000 permutations, there were no significant differences between the high myopia and control groups (Table 2).

Discussion

GWAS has been used to successfully identify susceptibility SNPs and genes in many complex disorders, such as diabetes mellitus [31], obesity [32], prostatic cancer [33], and aged-related macular degeneration [34-36]. However, a key question of GWAS is whether or not the results can be replicated in subjects of different ethnicities. The aim of this study was to determine if the BLID and LOC399959 genes are disease susceptibility loci for high myopia in the Chinese Han population. The SNP rs577948 was the first to be validated by GWAS as a high myopia susceptibility locus in Japanese subjects [27]. However in the Chinese Han population, we found no significant association with high myopic patients and controls by genotyping 19 tSNPs, including rs577948, of the BLID and LOC399959 genes.

This study can be seen as the second stage of a traditional GWAS analysis. Therefore we used the GWApower [37], a R package for assessing the power of genome-wide association studies, as the simulation tool to compare the detection power of our sample size with the previous study in a Japanese population. With the p-value threshold of 10−6, relative risk of 1.5, and MAF of 0.4 according to their first stage results [37], the power of Japanese second stage study with 533 cases and 977 controls is 0.132. That is much higher than ours at 0.018. However, the criteria for the control subjects in our study are more stringent, and our health controls enabled us to get a higher relative risk value in the current sample size. Using 1.7 as the relative risk, the power of our study reached 0.114, which means that our study has the same power to detect the association signal in LOC399959 as in the Japanese study.

In addition, by both χ2 test and logistic regression, the mean ages were significantly different between our samples and the Japanese study for both cases and controls. However, this should not impact our conclusion because high myopia is an early onset disease, usually occurring no later than the puberty years. In neither study was gender distribution completely matched for case and control groups. This should also not influence the conclusions as gender is not correlated with the occurrence of high myopia.

There may be two reasons that our results do not replicate those of the Japanese study. First, high myopia is a complex disease that is associated with high genetic heterogeneity. With studies that use different recruitment criteria, the genetic background of the patients selected for analysis could differ significantly from one another. Second, study populations composed of different ethnicities will have different genetic backgrounds. For these populations, the allelic frequencies of SNPs are likely to be different.

Thus far, the results are very limited for replication studies that have attempted to verify myopia susceptibility genes identified in association studies. This is not a surprise since it is common in complex diseases that the significant association signals in one investigation appear to be negative in other analyses. There may be several reasons for such phenomena, including different genetic backgrounds between populations and minor diversity in sample collection, clinical measurement, and statistical analysis. Considering the relatively minor contribution of each genetic factor to a complex disease in comparison with Mendelian inheritance, trivial diversity may result in differences in significance for an association signal. Furthermore, various ethnic groups may have different susceptibility genes in one disease-related pathway. Therefore, although our findings did not confirm that the BLID and LOC399959 genes play a genetic role in Chinese patients with high myopia, we cannot rule out the possibility that other susceptibility genes in related molecular pathways may be involved. Also, for any associated candidate gene, perhaps meta-analysis, i.e., the combination of several high myopia association studies, will be the ultimate method for determination of a true or false positive signal, as shown by recent association studies on diabetes and a few other complex diseases [38-43]. To reach this goal, certainly more independent association studies in various ethnicities are needed.

Acknowledgments

The authors wish to thank participants from the study who made this work possible. This work was supported by Zhejiang Provincial Natural Science Foundation of China (R205739), the Key Research and Development Program project Grant 2008C14097 from Zhejiang Province, the Development Program project grant Y2004A006 from Wenzhou, China and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, National 863 Project (2009AA022701) and National Natural Science Foundation of China (30671147).

References
  1. Hosaka A. Population studies–myopia experience in Japan. Acta Ophthalmol Suppl. 1988; 185:37-40. [PMID: 2853537]
  2. Paluru P, Ronan SM, Heon E, Devoto M, Wildenberg SC, Scavello G, Holleschau A, Makitie O, Cole WG, King RA, Young TL. New locus for autosomal dominant high myopia maps to the long arm of chromosome 17. Invest Ophthalmol Vis Sci. 2003; 44:1830-6. [PMID: 12714612]
  3. Sawada A, Tomidokoro A, Araie M, Iwase A, Yamamoto T. Refractive errors in an elderly Japanese population: the Tajimi study. Ophthalmology. 2008; 115:363-70. [PMID: 18243904]
  4. Katz J, Tielsch JM, Sommer A. Prevalence and risk factors for refractive errors in an adult inner city population. Invest Ophthalmol Vis Sci. 1997; 38:334-40. [PMID: 9040465]
  5. Wong TY, Foster PJ, Hee J, Ng TP, Tielsch JM, Chew SJ, Johnson GJ, Seah SK. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci. 2000; 41:2486-94. [PMID: 10937558]
  6. Schwartz M, Haim M, Skarsholm D. X-linked myopia: Bornholm eye disease. Linkage to DNA markers on the distal part of Xq. Clin Genet. 1990; 38:281-6. [PMID: 1980096]
  7. Young TL, Ronan SM, Drahozal LA, Wildenberg SC, Alvear AB, Oetting WS, Atwood LD, Wilkin DJ, King RA. Evidence that a locus for familial high myopia maps to chromosome 18p. Am J Hum Genet. 1998; 63:109-19. [PMID: 9634508]
  8. Young TL, Ronan SM, Alvear AB, Wildenberg SC, Oetting WS, Atwood LD, Wilkin DJ, King RA. A second locus for familial high myopia maps to chromosome 12q. Am J Hum Genet. 1998; 63:1419-24. [PMID: 9792869]
  9. Ciner E, Wojciechowski R, Ibay G, Bailey-Wilson JE, Stambolian D. Genomewide scan of ocular refraction in African-American families shows significant linkage to chromosome 7p15. Genet Epidemiol. 2008; 32:454-63. [PMID: 18293391]
  10. Zhang Q, Guo X, Xiao X, Jia X, Li S, Hejtmancik JF. A new locus for autosomal dominant high myopia maps to 4q22-q27 between D4S1578 and D4S1612. Mol Vis. 2005; 11:554-60. [PMID: 16052171]
  11. Paluru PC, Nallasamy S, Devoto M, Rappaport EF, Young TL. Identification of a novel locus on 2q for autosomal dominant high-grade myopia. Invest Ophthalmol Vis Sci. 2005; 46:2300-7. [PMID: 15980214]
  12. Zhang Q, Guo X, Xiao X, Jia X, Li S, Hejtmancik JF. Novel locus for X linked recessive high myopia maps to Xq23-q25 but outside MYP1. J Med Genet. 2006; 43:e20 [PMID: 16648373]
  13. Nallasamy S, Paluru PC, Devoto M, Wasserman NF, Zhou J, Young TL. Genetic linkage study of high-grade myopia in a Hutterite population from South Dakota. Mol Vis. 2007; 13:229-36. [PMID: 17327828]
  14. Lam CY, Tam PO, Fan DS, Fan BJ, Wang DY, Lee CW, Pang CP, Lam DS. A genome-wide scan maps a novel high myopia locus to 5p15. Invest Ophthalmol Vis Sci. 2008; 49:3768-78. [PMID: 18421076]
  15. Yang Z, Xiao X, Li S, Zhang Q. Clinical and linkage study on a consanguineous Chinese family with autosomal recessive high myopia. Mol Vis. 2009; 15:312-8. [PMID: 19204786]
  16. Inamori Y, Ota M, Inoko H, Okada E, Nishizaki R, Shiota T, Mok J, Oka A, Ohno S, Mizuki N. The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet. 2007; 122:151-7. [PMID: 17557158]
  17. Lin HJ, Wan L, Tsai Y, Tsai YY, Fan SS, Tsai CH, Tsai FJ. The TGFbeta1 gene codon 10 polymorphism contributes to the genetic predisposition to high myopia. Mol Vis. 2006; 12:698-703. [PMID: 16807529]
  18. Zha Y, Leung KH, Lo KK, Fung WY, Ng PW, Shi MG, Yap MK, Yip SP. TGFB1 as a susceptibility gene for high myopia: a replication study with new findings. Arch Ophthalmol. 2009; 127:541-8. [PMID: 19365037]
  19. Lam DS, Lee WS, Leung YF, Tam PO, Fan DS, Fan BJ, Pang CP. TGFbeta-induced factor: a candidate gene for high myopia. Invest Ophthalmol Vis Sci. 2003; 44:1012-5. [PMID: 12601022]
  20. Chen ZT, Wang IJ, Shih YF, Lin LL. The association of haplotype at the lumican gene with high myopia susceptibility in Taiwanese patients. Ophthalmology. 2009; 116:1920-7. [PMID: 19616852]
  21. Lin HJ, Wan L, Tsai Y, Chen WC, Tsai SW, Tsai FJ. The association between lumican gene polymorphisms and high myopia. Eye (Lond). 2010; 24:1093-101. [PMID: 20010793]
  22. Han W, Yap MK, Wang J, Yip SP. Family-based association analysis of hepatocyte growth factor (HGF) gene polymorphisms in high myopia. Invest Ophthalmol Vis Sci. 2006; 47:2291-9. [PMID: 16723436]
  23. Tang WC, Yip SP, Lo KK, Ng PW, Choi PS, Lee SY, Yap MK. Linkage and association of myocilin (MYOC) polymorphisms with high myopia in a Chinese population. Mol Vis. 2007; 13:534-44. [PMID: 17438518]
  24. Hewitt AW, Kearns LS, Jamieson RV, Williamson KA, van Heyningen V, Mackey DA. PAX6 mutations may be associated with high myopia. Ophthalmic Genet. 2007; 28:179-82. [PMID: 17896318]
  25. Han W, Leung KH, Fung WY, Mak JY, Li YM, Yap MK, Yip SP. Association of PAX6 polymorphisms with high myopia in Han Chinese nuclear families. Invest Ophthalmol Vis Sci. 2009; 50:47-56. [PMID: 19124844]
  26. Nishizaki R, Ota M, Inoko H, Meguro A, Shiota T, Okada E, Mok J, Oka A, Ohno S, Mizuki N. New susceptibility locus for high myopia is linked to the uromodulin-like 1 (UMODL1) gene region on chromosome 21q22.3. Eye (Lond). 2009; 23:222-9. [PMID: 18535602]
  27. Nakanishi H, Yamada R, Gotoh N, Hayashi H, Yamashiro K, Shimada N, Ohno-Matsui K, Mochizuki M, Saito M, Iida T, Matsuo K, Tajima K, Yoshimura N, Matsuda F. A genome-wide association analysis identified a novel susceptible locus for pathological myopia at 11q24.1. PLoS Genet. 2009; 5:e1000660 [PMID: 19779542]
  28. International_HapMap_Consortium. A haplotype map of the human genome. Nature. 2005; 437:1299-320. [PMID: 16255080]
  29. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L, Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L, Liu Y, Shen Y, Sun W, Wang H, Wang Y, Wang Y, Xiong X, Xu L, Waye MM, Tsui SK, Xue H, Wong JT, Galver LM, Fan JB, Gunderson K, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon F, Ferretti V, Leboeuf M, Olivier JF, Phillips MS, Roumy S, Sallee C, Verner A, Hudson TJ, Kwok PY, Cai D, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui LC, Mak W, Song YQ, Tam PK, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A, Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird CP, Delgado M, Dermitzakis ET, Gwilliam R, Hunt S, Morrison J, Powell D, Stranger BE, Whittaker P, Bentley DR, Daly MJ, de Bakker PI, Barrett J, Chretien YR, Maller J, McCarroll S, Patterson N, Pe'er I, Price A, Purcell S, Richter DJ, Sabeti P, Saxena R, Schaffner SF, Sham PC, Varilly P, Altshuler D, Stein LD, Krishnan L, Smith AV, Tello-Ruiz MK, Thorisson GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Lin S, Abecasis GR, Guan W, Li Y, Munro HM, Qin ZS, Thomas DJ, McVean G, Auton A, Bottolo L, Cardin N, Eyheramendy S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M, Donnelly P, Cardon LR, Clarke G, Evans DM, Morris AP, Weir BS, Tsunoda T, Mullikin JC, Sherry ST, Feolo M, Skol A, Zhang H, Zeng C, Zhao H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Ajayi I, Aniagwu T, Marshall PA, Nkwodimmah C, Royal CD, Leppert MF, Dixon M, Peiffer A, Qiu R, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers BM, Foster MW, Clayton EW, Watkin J, Gibbs RA, Belmont JW, Muzny D, Nazareth L, Sodergren E, Weinstock GM, Wheeler DA, Yakub I, Gabriel SB, Onofrio RC, Richter DJ, Ziaugra L, Birren BW, Daly MJ, Altshuler D, Wilson RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM, Griffiths M, Jones MC, McLay K, Plumb RW, Ross MT, Sims SK, Willey DL, Chen Z, Han H, Kang L, Godbout M, Wallenburg JC, L'Archeveque P, Bellemare G, Saeki K, Wang H, An D, Fu H, Li Q, Wang Z, Wang R, Holden AL, Brooks LD, McEwen JE, Guyer MS, Wang VO, Peterson JL, Shi M, Spiegel J, Sung LM, Zacharia LF, Collins FS, Kennedy K, Jamieson R, Stewart J. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007; 449:851-61. [PMID: 17943122]
  30. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263-5. [PMID: 15297300]
  31. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445:881-5. [PMID: 17293876]
  32. Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF, Levy S, Papasian CJ, Drees BM, Hamilton JJ, Meyre D, Delplanque J, Pei YF, Zhang L, Recker RR, Froguel P, Deng HW. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008; 17:1803-13. [PMID: 18325910]
  33. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindstrom S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet. 2008; 40:281-3. [PMID: 18264098]
  34. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308:385-9. [PMID: 15761122]
  35. Edwards AO, Ritter R, , 3rd Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308:421-4. [PMID: 15761121]
  36. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308:419-21. [PMID: 15761120]
  37. Spencer CC, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet. 2009; 5:e1000477 [PMID: 19492015]
  38. Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Grundberg E, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra B, Pastinen T, Pols HA, Sigurdsson G, Soranzo N, Thorleifsson G, Thorsteinsdottir U, Williams FM, Wilson SG, Zhou Y, Ralston SH, van Duijn CM, Spector T, Kiel DP, Stefansson K, Ioannidis JP, Uitterlinden AG. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41:1199-206. [PMID: 19801982]
  39. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, Hauser SL, Hafler DA, Oksenberg JR. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009; 41:776-82. [PMID: 19525953]
  40. Perry JR, Stolk L, Franceschini N, Lunetta KL, Zhai G, McArdle PF, Smith AV, Aspelund T, Bandinelli S, Boerwinkle E, Cherkas L, Eiriksdottir G, Estrada K, Ferrucci L, Folsom AR, Garcia M, Gudnason V, Hofman A, Karasik D, Kiel DP, Launer LJ, van Meurs J, Nalls MA, Rivadeneira F, Shuldiner AR, Singleton A, Soranzo N, Tanaka T, Visser JA, Weedon MN, Wilson SG, Zhuang V, Streeten EA, Harris TB, Murray A, Spector TD, Demerath EW, Uitterlinden AG, Murabito JM. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet. 2009; [PMID: 19011631]
  41. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS, Kerr D, Cazier JB, Niittymaki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Volzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008; 40:1426-35. [PMID: 19011631]
  42. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, Warram JH, Todd JA. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet. 2008; 40:1399-401. [PMID: 18978792]
  43. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostrom KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C, Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU, Jorgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF, Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N, Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A, Shields B, Sjogren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorleifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker M, Watanabe RM, Weedon MN, Willer CJ, Illig T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L, McCarthy MI, Boehnke M, Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40:638-45. [PMID: 18372903]